drugset / Trial / NCT02502721

A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

NCT02502721 ↗

Phase 1 Completed 58 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-labeled, oral dose, crossover design clinical trial to evaluate pharmacokinetics and safety between DWC20151 and DWC20152 in healthy male subjects.

Timeline

Start
2015-06
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC20151 Unknown — Oral
Subject DWC20152 Unknown — Oral

Indications

No indication recorded.